Company Overview and News

to your dashboard

Headline News

Teva: Et Tu, Moody's?

20h seekingalpha
Yields a certain tranche of long-term debt exceeds 6%. It may have to refinance maturing debt in a rising rate environment. (129-2)

Foreign Stock Roundup: Taiwan Semiconductor Beats, Shell Buys Stake in Silicon Ranch

20h zacks
Global markets largely echoed Wall Street’s fortunes over last week. Stocks across Europe were buoyed by notable earnings performances and strong economic data. Meanwhile, in Asia, the Nikkei lingered near 26-year highs while encouraging growth numbers buoyed China’s stocks. A bullish economic outlook helped stocks in Brazil scale new highs during this period. STOXX Gains on Strong Economic Data, Earnings Volumes remained low across Europe on last Monday as markets took a breather after two weeks of notable gains. (197-0)

Teva shares decline on negative late-stage trial results for asthma therapy - MarketWatch

22h marketwatch
Teva Pharmaceutical Industries Ltd. shares TEVA, -0.05% slid 3% premarket Monday, after the company said a late-stage trial of an asthma treatment failed to meet its main goal. The company said the therapy, subcutaneously administered reslizumab, failed to meet its primary endpoint in two phase 3 studies, one of which focused on reducing frequency of clinical asthma exacerbations and the other of which focused on reducing daily oral corticosteroid dose in patients with OCS-dependent asthma. (129-0)

Delaware sues opioid manufacturers, distributors over epidemic

2018-01-19 reuters
(Reuters) - Delaware on Friday became the latest state to file a lawsuit accusing corporations of helping fuel the national opioid epidemic, suing a wide range of companies involved in making, distributing and selling prescription painkillers. (207-0)

Generic-Drug Makers Fall as Justice Department Threatens to Sue - Bloomberg

2018-01-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (151-0)

UPDATE 1-U.S. hospital systems team up to launch generic drugmaker

2018-01-18 reuters
NEW YORK, Jan 18 (Reuters) - A group of four hospital systems plans to launch a not-for-profit generic drugmaker aimed at combating shortages and high costs of some generic drugs, which they blame on unscrupulous drug companies that hike prices. (218-0)

Strong UnitedHealth Group Inc Earnings Keep Rally Going

2018-01-16 investorplace
It’s exceedingly difficult to find something to dislike about UnitedHealth Group Inc (NYSE:UNH) stock. In a healthcare sector filled with minefields over the past few years, UnitedHealth stock has tripled over the past four years. Valuation might seem a slight concern, but UNH stock isn’t that expensive on an earnings basis, nor is its balance sheet particularly levered. (353-0)

Teva's Trisenox Gets FDA Approval as First-Line Treatment

2018-01-16 zacks
Teva Pharmaceutical Industries Ltd. (TEVA - Free Report) announced that the FDA has approved the label expansion of Trisenox injection to include first-line treatment of acute promyelocytic leukemia (“APL”) patients in combination with tretinoin. (197-0)

Teva's Debt Cut to Junk by Moody's, Adding to Drugmaker's Woes - Bloomberg

2018-01-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (197-0)

Why Mizuho Securities Upgraded Teva Pharmaceutical to a ‘Buy’

On January 9, 2018, Mizuho Securities upgraded Teva Pharmaceutical Industries (TEVA) from a “neutral” to a “buy” rating. Mizuho is a leading Japanese investment banking firm. Analyst Irina Koffler at Mizuho raised the price target on TEVA stock from $16 to $23. The stock rose 1.4% that day, and the BLDRS Europe Select ADR ETF (ADRU) fell 0.28%. TEVA makes up 0.51% of ADRU’s total portfolio holdings. (163-0)

Judge seeking settlement of opioid lawsuits reaches out to states: Ohio - Channel NewsAsia

2018-01-11 channelnewsasia
REUTERS: A federal judge pushing for a quick settlement of lawsuits against opioid manufacturers and distributors by U.S. cities and counties is seeking to meet with states that are separately suing and probing the companies, Ohio's attorney general said on Thursday. (272-0)

Ohio in Talks to Settle Opioid Suit, State Attorney General Says - WSJ

2018-01-11 wsj
Ohio’s attorney general said the state has begun settlement talks with two opioid-painkiller makers—Johnson & Johnson and Teva Pharmaceutical Industries Ltd.—concerning the state’s lawsuit alleging illegal marketing of the drugs. (129-0)

AstraZeneca's Asthma Drug Benralizumab Gets Approval in EU

2018-01-11 zacks
AstraZeneca, plc (AZN - Free Report) announced that the European Commission (“EC”) has granted approval to its asthma disease candidate, benralizumab. It is approved as an add-on maintenance treatment for severe eosinophilic asthma in adult patients. It will be marketed by the trade name of Fasenra. (344-0)

Earnings Visibility Keep Teva Pharmaceutical Industries (TEVA) a Sell

2018-01-10 investorplace
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) is classified as a member of the 15 company Pharmaceuticals: Generic GICS industry group, which is part of the 656 company GICS Health Technology sector. TEVA's market value is $19.5 billion which places it in the upper half of its industry group. The stock's current Portfolio Grader ranking places it 12 among the 15 companies in this industry group, a spot that is well below-average; squarely in the bottom quartile of the sector with a ranking of 571 among the 656 companies in the sector, and number 4,066 in the nearly 5,000 company Portfolio Grader universe. (129-2)

Teva Pharm directors cut their salaries in half: board member - Channel NewsAsia

2018-01-10 channelnewsasia
The board of directors at Teva Pharmaceutical Industries , which is reducing its workforce by more than a quarter as part of a global overhaul, has taken a 50 percent pay cut, a board member said on Wednesday. (129-0)

CUSIP: EP0496760